Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity
- 29 August 2001
- journal article
- clinical trial
- Published by Springer Nature in Molecular Psychiatry
- Vol. 6 (5) , 586-592
- https://doi.org/10.1038/sj.mp.4000876
Abstract
Molecular Psychiatry publishes work aimed at elucidating biological mechanisms underlying psychiatric disorders and their treatmentKeywords
This publication has 51 references indexed in Scilit:
- Allelic Variation in the Serotonin Transporter Promoter Affects Onset of Paroxetine Treatment Response in Late-Life DepressionNeuropsychopharmacology, 2000
- TPH Gene May Be Associated with Suicidal Behavior, but Not with Schizophrenia in the Korean PopulationHuman Heredity, 2000
- The 5′ region of the tryptophan hydroxylase gene: mutation search and association study with alcoholismJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- Population Studies of Polymorphisms at Loci of Neuropsychiatric Interest (Tryptophan Hydroxylase (TPH), Dopamine Transporter Protein (SLC6A3), D3 Dopamine Receptor (DRD3), Apolipoprotein E (APOE), μ Opioid Receptor (OPRM1), and Ciliary Neurotrophic Factor (CNTF))Genomics, 1998
- Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigreesJournal of Psychiatric Research, 1998
- Who's afraid of epistasis?Nature Genetics, 1996
- Association of Anxiety-Related Traits with a Polymorphism in the Serotonin Transporter Gene Regulatory RegionScience, 1996
- Allelic Variation of Human Serotonin Transporter Gene ExpressionJournal of Neurochemistry, 1996
- L-Tryptophan in Neuropsychiatry Disorders: A ReviewInternational Journal of Neuroscience, 1992
- DIFFERENTIATION OF TWO GENETICALLY SPECIFIC TYPES OF DEPRESSION BY THE RESPONSE TO ANTI-DEPRESSANTSThe Lancet, 1962